Launch of Multi-Symptom Cold Relief "Pabron AG Tablet" Contains Mequitazine to Reduce Sneezing, a Runny Nose and Nasal Congestion

Taisho Pharmaceutical Co., Ltd. (President: Akira Uehara) will release Pabron AG Tablet on August 23. This cold and flu medication is particularly effective for the relief of sneezing, a runny nose and nasal congestion.

Pabron AG Tablet has antiallergic and antihistamic effects. It is the first Pabron preparation to include mequitazine, which is well known for its effectiveness in alleviating symptoms such as sneezing, a runny nose and nasal congestion. Pabron AG Tablet also contains 7 other active ingredients, including bromhexine hydrochloride, to effectively alleviate various cold symptoms. These tablets are small, and therefore easy to take. 

In 1927, Taisho Pharmaceutical released Pabron as a cough suppressant and expectorant. Since then, we have been responding to the needs of consumers by extending the range of products in the Pabron series, improving ingredients, and developing new products. The Pabron brand provides a comprehensive selection of cold and flu medications. The release of Pabron AG Tablet will strengthen the Pabron series for cold and flu relief.